Synergic Effects of Berberine and Curcumin on Improving Cognitive Function in an Alzheimer's Disease Mouse Model - PubMed (original) (raw)
. 2020 May;45(5):1130-1141.
doi: 10.1007/s11064-020-02992-6. Epub 2020 Feb 21.
Affiliations
- PMID: 32080784
- DOI: 10.1007/s11064-020-02992-6
Synergic Effects of Berberine and Curcumin on Improving Cognitive Function in an Alzheimer's Disease Mouse Model
Lin Lin et al. Neurochem Res. 2020 May.
Abstract
Alzheimer's disease (AD) is one of the most common neurodegenerative diseases, and no effective therapies have been found to prevent or cure AD to date. Berberine and curcumin are extracts from traditional Chinese herbs that have a long history of clinical benefits for AD. Here, using a transgenic AD mouse model, we found that the combined berberine and curcumin treatment had a much better effect on improving the cognitive function of mice than the single-drug treatment, suggesting synergic effects of the combined berberine and curcumin treatment. In addition, we found that the combined berberine and curcumin treatment had significant synergic effects on reducing soluble amyloid-β-peptide(1-42) production. Furthermore, the combination treatment also had remarkable synergic effects on decreasing inflammatory responses and oxidative stress in both the cortex and hippocampus of AD mice. We also found that the combination treatment performed much better than the single drugs in reducing the APP and BACE1 levels and increasing AMPKα phosphorylation and cell autophagy, which might be the underlying mechanism of the synergic effects. Taken together, the result of this study reveal the synergic effects and potential underlying mechanisms of the combined berberine and curcumin treatment in improving the symptoms of AD in mice. This study sheds light on a new strategy for exploring new phytotherapies for AD and also emphasizes that more research should focus on the synergic effects of herbal drugs in the future.
Keywords: Alzheimer’s disease; Berberine; Cognitive function; Curcumin; Inflammatory responses; Oxidative stress.
Similar articles
- Curcumin Ameliorates Memory Decline via Inhibiting BACE1 Expression and β-Amyloid Pathology in 5×FAD Transgenic Mice.
Zheng K, Dai X, Xiao N, Wu X, Wei Z, Fang W, Zhu Y, Zhang J, Chen X. Zheng K, et al. Mol Neurobiol. 2017 Apr;54(3):1967-1977. doi: 10.1007/s12035-016-9802-9. Epub 2016 Feb 24. Mol Neurobiol. 2017. PMID: 26910813 - Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z, Wang C, He W, Chen Y. Cai Z, et al. Curr Alzheimer Res. 2018;15(11):1045-1052. doi: 10.2174/1567205015666180702105740. Curr Alzheimer Res. 2018. PMID: 29962345 - Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
Huang M, Jiang X, Liang Y, Liu Q, Chen S, Guo Y. Huang M, et al. Exp Gerontol. 2017 May;91:25-33. doi: 10.1016/j.exger.2017.02.004. Epub 2017 Feb 20. Exp Gerontol. 2017. PMID: 28223223 - Development and Structural Modification of BACE1 Inhibitors.
Gu T, Wu WY, Dong ZX, Yu SP, Sun Y, Zhong Y, Lu YT, Li NG. Gu T, et al. Molecules. 2016 Dec 22;22(1):4. doi: 10.3390/molecules22010004. Molecules. 2016. PMID: 28025519 Free PMC article. Review. - BACE1 in Alzheimer's disease.
Sathya M, Premkumar P, Karthick C, Moorthi P, Jayachandran KS, Anusuyadevi M. Sathya M, et al. Clin Chim Acta. 2012 Dec 24;414:171-8. doi: 10.1016/j.cca.2012.08.013. Epub 2012 Aug 20. Clin Chim Acta. 2012. PMID: 22926063 Review.
Cited by
- Antioxidants in Alzheimer's Disease: Current Therapeutic Significance and Future Prospects.
Pritam P, Deka R, Bhardwaj A, Srivastava R, Kumar D, Jha AK, Jha NK, Villa C, Jha SK. Pritam P, et al. Biology (Basel). 2022 Jan 28;11(2):212. doi: 10.3390/biology11020212. Biology (Basel). 2022. PMID: 35205079 Free PMC article. Review. - The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study.
Wade U, Pascual-Figal DA, Rabbani F, Ernst M, Albert A, Janssens I, Dierckxsens Y, Iqtadar S, Khokhar NA, Kanwal A, Khan A. Wade U, et al. Nutrients. 2024 Apr 18;16(8):1204. doi: 10.3390/nu16081204. Nutrients. 2024. PMID: 38674895 Free PMC article. - Intranasally Co-administered Berberine and Curcumin Loaded in Transfersomal Vesicles Improved Inhibition of Amyloid Formation and BACE-1.
Mishra G, Awasthi R, Singh AK, Singh S, Mishra SK, Singh SK, Nandi MK. Mishra G, et al. ACS Omega. 2022 Nov 14;7(47):43290-43305. doi: 10.1021/acsomega.2c06215. eCollection 2022 Nov 29. ACS Omega. 2022. PMID: 36467923 Free PMC article. - Effectiveness of Novel Drug Delivery System using Curcumin in Alzheimer's Disease.
Aswar U, Rathod K, Mathure D. Aswar U, et al. Cent Nerv Syst Agents Med Chem. 2024;24(3):281-293. doi: 10.2174/0118715249279534240214111155. Cent Nerv Syst Agents Med Chem. 2024. PMID: 38409724 Review. - Role of traditional Chinese medicine in ameliorating mitochondrial dysfunction via non-coding RNA signaling: Implication in the treatment of neurodegenerative diseases.
Cai Z, Liu M, Zeng L, Zhao K, Wang C, Sun T, Li Z, Liu R. Cai Z, et al. Front Pharmacol. 2023 Mar 1;14:1123188. doi: 10.3389/fphar.2023.1123188. eCollection 2023. Front Pharmacol. 2023. PMID: 36937876 Free PMC article. Review.
References
- Life Sci. 2007 Aug 23;81(11):933-8 - PubMed
- Autophagy. 2019 Mar;15(3):478-492 - PubMed
- Transl Neurodegener. 2013 Feb 28;2(1):6 - PubMed
- J Neurosci. 2008 Nov 5;28(45):11622-34 - PubMed
- Nat Neurosci. 2007 Mar;10(3):355-62 - PubMed
MeSH terms
Substances
Grants and funding
- 18Z081/the soft science of Sichuan Provincial Science and Technology Department
- 2018KF016/State Administration of Traditional Chinese Medicine of the People's Republic of China (CN)
LinkOut - more resources
Full Text Sources
Medical